Navigation Links
Valeant Pharmaceuticals to Present at Cowen and Company 29th Annual Health Care Conference
Date:3/11/2009

ALISO VIEJO, Calif., March 11 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced members of its senior management team will make a presentation at the Cowen and Company 29th Annual Health Care Conference on Tuesday, March 17, 2009 at 2:25 p.m. EDT. The conference will be held at the Boston Marriott Copley Place in Boston, MA.

A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast also can be accessed through the following URL: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VRX&item_id=2110966

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.

    Contact:
    Laurie Little
    Valeant Pharmaceuticals
    949-461-6002

(Logo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO)


'/>"/>
SOURCE Valeant Pharmaceuticals International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date
2. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
3. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
4. Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
5. ISTA Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
6. Biostar Pharmaceuticals, Inc. Completes 8.6-Acre Land Purchase to House New Raw Materials Processing Plant
7. Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
9. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
10. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
11. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... , ... Axiad IDS , a leading provider of trusted identities for ... company a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor ... proactively address potential cybersecurity threats before they happen. The annual list of ...
(Date:5/23/2017)... ... May 23, 2017 , ... i2i Population Health, a national ... category winner, has named Daniel P. Bullington as chief technology officer. , “i2i ... and product offerings,” says Justin Neece, president. “Daniel is an excellent fit for ...
(Date:5/23/2017)... Las Vegas, NV (PRWEB) , ... May 23, ... ... with Significance Dental Specialists, are educating patients on peri-implantitis in Las ... new patients to receive a custom gum disease consultation and leading care for ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... New ... gums and chronic bad breath, can now receive laser gum disease treatments from the ... Douglas Campbell and David Landau are raising awareness of the importance of receiving qualified ...
(Date:5/22/2017)... ... ... Patients who avoid necessary dental and endodontic treatments because of dental ... Advanced Endodontics of Westchester. This highly-trained team of endodontists offer three different sedation methods ... may be recommended based on the severity of the anxiety experienced by each patient. ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... Pa. , May 4, 2017  A ... from thermoplastics and other highly-engineered materials, is being ... Microextrusion tubing has been developed in recent years ... interventional therapies and surgical applications. More expensive materials ... to produce microextrusion tubing due to their ability ...
(Date:5/3/2017)... May 3, 2017  Getinge, a leading global ... quality enhancement and cost efficiency within healthcare and ... of contemporary practice demonstrating that intra-aortic balloon counterpulsation ... critically ill patients. The single-center, retrospective, observational study ... volume MEGA ® 50cc intra-aortic balloon (IAB) ...
(Date:5/2/2017)... , May 2, 2017  CIVCO Radiotherapy, ... radiotherapy solutions, announced today that Nat Geissel ... with CIVCO since 2012 and has served as ... senior vice president and general manager, and most ... "I am extremely proud of what CIVCO ...
Breaking Medicine Technology: